Becton Beats FDA Approval Claims In Securities Suit
A New Jersey federal judge has nixed class claims that medical technology manufacturer Becton Dickinson & Co. hid that changes to its Alaris infusion pumps needed clearance through the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article